Exogenous nitric oxide increases basal leg glucose uptake in humans

William J. Durham, Catherine W. Yeckel, Sharon L. Miller, Dennis Gore, Robert R. Wolfe

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

This study addressed the role of blood flow and nitric oxide in leg glucose uptake. Seven subjects (5 men, 2 women) were studied during conditions of resting blood flow and increased blood flow, achieved by infusion of the nitric oxide (NO) donor sodium nitroprusside (SNP) into the femoral artery. Femoral arterial and venous blood samples were obtained and blood flow was determined by infusion of indocyanine green dye. SNP infusion significantly increased leg blood flow (769 ± 103 v 450 ± 65 mL.min-1.leg-1, P < .001), but did not affect arterial (4.68 ± 0.13 mmol/L control, 4.63 ± 0.09 mmol/L SNP) or venous (4.60 ± 0.14 mmol/L control, 4.54 ± 0.10 mmol/L SNP) glucose concentrations. Glucose uptake was significantly (P < .01) higher during SNP infusion (65 ± 6 μmol.min-1.leg-1) than during the basal period (34 ± 6 μmol.min-1.leg-1), whereas lactate release was unaffected (rest, 45 ± 11 μmol.min-1.leg-1; SNP, 42 ± 14 μmol.min-1.leg-1). We conclude that blood flow and/or NO increase basal leg glucose uptake.

Original languageEnglish (US)
Pages (from-to)662-665
Number of pages4
JournalMetabolism: Clinical and Experimental
Volume52
Issue number6
DOIs
StatePublished - Jun 1 2003
Externally publishedYes

Fingerprint

Leg
Nitric Oxide
Nitroprusside
Glucose
Indocyanine Green
Nitric Oxide Donors
Femoral Artery
Thigh
Lactic Acid
Coloring Agents

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Exogenous nitric oxide increases basal leg glucose uptake in humans. / Durham, William J.; Yeckel, Catherine W.; Miller, Sharon L.; Gore, Dennis; Wolfe, Robert R.

In: Metabolism: Clinical and Experimental, Vol. 52, No. 6, 01.06.2003, p. 662-665.

Research output: Contribution to journalArticle

Durham, William J. ; Yeckel, Catherine W. ; Miller, Sharon L. ; Gore, Dennis ; Wolfe, Robert R. / Exogenous nitric oxide increases basal leg glucose uptake in humans. In: Metabolism: Clinical and Experimental. 2003 ; Vol. 52, No. 6. pp. 662-665.
@article{265fcd96059348f0baa150c089fc8e40,
title = "Exogenous nitric oxide increases basal leg glucose uptake in humans",
abstract = "This study addressed the role of blood flow and nitric oxide in leg glucose uptake. Seven subjects (5 men, 2 women) were studied during conditions of resting blood flow and increased blood flow, achieved by infusion of the nitric oxide (NO) donor sodium nitroprusside (SNP) into the femoral artery. Femoral arterial and venous blood samples were obtained and blood flow was determined by infusion of indocyanine green dye. SNP infusion significantly increased leg blood flow (769 ± 103 v 450 ± 65 mL.min-1.leg-1, P < .001), but did not affect arterial (4.68 ± 0.13 mmol/L control, 4.63 ± 0.09 mmol/L SNP) or venous (4.60 ± 0.14 mmol/L control, 4.54 ± 0.10 mmol/L SNP) glucose concentrations. Glucose uptake was significantly (P < .01) higher during SNP infusion (65 ± 6 μmol.min-1.leg-1) than during the basal period (34 ± 6 μmol.min-1.leg-1), whereas lactate release was unaffected (rest, 45 ± 11 μmol.min-1.leg-1; SNP, 42 ± 14 μmol.min-1.leg-1). We conclude that blood flow and/or NO increase basal leg glucose uptake.",
author = "Durham, {William J.} and Yeckel, {Catherine W.} and Miller, {Sharon L.} and Dennis Gore and Wolfe, {Robert R.}",
year = "2003",
month = "6",
day = "1",
doi = "10.1016/S0026-0495(03)00062-3",
language = "English (US)",
volume = "52",
pages = "662--665",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Exogenous nitric oxide increases basal leg glucose uptake in humans

AU - Durham, William J.

AU - Yeckel, Catherine W.

AU - Miller, Sharon L.

AU - Gore, Dennis

AU - Wolfe, Robert R.

PY - 2003/6/1

Y1 - 2003/6/1

N2 - This study addressed the role of blood flow and nitric oxide in leg glucose uptake. Seven subjects (5 men, 2 women) were studied during conditions of resting blood flow and increased blood flow, achieved by infusion of the nitric oxide (NO) donor sodium nitroprusside (SNP) into the femoral artery. Femoral arterial and venous blood samples were obtained and blood flow was determined by infusion of indocyanine green dye. SNP infusion significantly increased leg blood flow (769 ± 103 v 450 ± 65 mL.min-1.leg-1, P < .001), but did not affect arterial (4.68 ± 0.13 mmol/L control, 4.63 ± 0.09 mmol/L SNP) or venous (4.60 ± 0.14 mmol/L control, 4.54 ± 0.10 mmol/L SNP) glucose concentrations. Glucose uptake was significantly (P < .01) higher during SNP infusion (65 ± 6 μmol.min-1.leg-1) than during the basal period (34 ± 6 μmol.min-1.leg-1), whereas lactate release was unaffected (rest, 45 ± 11 μmol.min-1.leg-1; SNP, 42 ± 14 μmol.min-1.leg-1). We conclude that blood flow and/or NO increase basal leg glucose uptake.

AB - This study addressed the role of blood flow and nitric oxide in leg glucose uptake. Seven subjects (5 men, 2 women) were studied during conditions of resting blood flow and increased blood flow, achieved by infusion of the nitric oxide (NO) donor sodium nitroprusside (SNP) into the femoral artery. Femoral arterial and venous blood samples were obtained and blood flow was determined by infusion of indocyanine green dye. SNP infusion significantly increased leg blood flow (769 ± 103 v 450 ± 65 mL.min-1.leg-1, P < .001), but did not affect arterial (4.68 ± 0.13 mmol/L control, 4.63 ± 0.09 mmol/L SNP) or venous (4.60 ± 0.14 mmol/L control, 4.54 ± 0.10 mmol/L SNP) glucose concentrations. Glucose uptake was significantly (P < .01) higher during SNP infusion (65 ± 6 μmol.min-1.leg-1) than during the basal period (34 ± 6 μmol.min-1.leg-1), whereas lactate release was unaffected (rest, 45 ± 11 μmol.min-1.leg-1; SNP, 42 ± 14 μmol.min-1.leg-1). We conclude that blood flow and/or NO increase basal leg glucose uptake.

UR - http://www.scopus.com/inward/record.url?scp=0038818985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038818985&partnerID=8YFLogxK

U2 - 10.1016/S0026-0495(03)00062-3

DO - 10.1016/S0026-0495(03)00062-3

M3 - Article

VL - 52

SP - 662

EP - 665

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 6

ER -